Enterprise League logo
Osivax Logo

Osivax

Lyon, France · Health and Medical

Do you work at Osivax?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#biotechnology

#immunology

#antigens

#vaccine

#influenza

#universal

#cellular immune response

#cd8 t-cell

#infectious diseases

#immuno-oncology

Osivax is a Health and Medical company based in Lyon, France, founded in 2017, with 30-50 employees. Osivax's profile is verified on Enterprise League.

Overview

Osivax’ mission is to develop “universal” vaccines against highly-mutating viruses. Leveraging its unique oligoDOM® technology platform, OSIVAX is developing a universal vaccine for both current and future influenza infections. The Company’s universal flu vaccine candidate, OVX836 is in Phase 2a clinical development. OSIVAX is leveraging the same platform technology for the development of a universal vaccine against all existing and emerging coronavirus infections. OSIVAX is focused on providing proof-of-concept in influenza and coronavirus, and to applying its oligoDOM® platform broadly in other infectious and immune system-associated diseases.
Visit Official Website

Most teams do this before shortlisting

Contact Details

+33(0)9 70 30 13 80
contact@osivax.com

Lyon, France, 70, Rue Saint-Jean-de-Dieu

+1

Founded

2017

Company Type

Private Limited Company

Employees

30-50

Categories

Clinical Trials
Healthcare
Biotechnology

Keywords

#biotechnology

#immunology

#antigens

#vaccine

#influenza

#universal

#cellular immune response

#cd8 t-cell

#infectious diseases

#immuno-oncology

Awards

• 2026 OpenSee all

Companies teams usually look at after Osivax

Comparing a few options usually leads to better decisions

  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.